6866-57-5 Usage
Uses
Used in Medicinal Chemistry:
2-(trifluoromethyl)-1H-benzo[d]imidazole-7-carboxylic acid is used as a building block for the synthesis of biologically active compounds. Its unique structure and functional groups make it a valuable component in the development of new pharmaceuticals.
Used in Drug Development:
2-(trifluoromethyl)-1H-benzo[d]imidazole-7-carboxylic acid is used as a promising candidate for the development of new pharmaceuticals. Its structural features and the presence of the trifluoromethyl group enhance its pharmacokinetic properties and biological activity, making it an attractive target for further research and development.
Used in Pharmaceutical Industry:
2-(trifluoromethyl)-1H-benzo[d]imidazole-7-carboxylic acid is used as a key intermediate in the synthesis of various drug molecules. Its unique structure and functional groups contribute to the development of innovative therapeutic agents with improved efficacy and safety profiles.
Used in Research and Development:
2-(trifluoromethyl)-1H-benzo[d]imidazole-7-carboxylic acid is used as a subject of research to explore its potential applications in various fields, including medicinal chemistry, drug development, and pharmaceutical industry. Its unique structural features and the presence of the trifluoromethyl group make it an attractive target for further investigation and development.
Check Digit Verification of cas no
The CAS Registry Mumber 6866-57-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,8,6 and 6 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6866-57:
(6*6)+(5*8)+(4*6)+(3*6)+(2*5)+(1*7)=135
135 % 10 = 5
So 6866-57-5 is a valid CAS Registry Number.
6866-57-5Relevant academic research and scientific papers
OXADIAZOLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
-
Paragraph 0257; 0258; 0261, (2017/02/02)
PROBLEM TO BE SOLVED: To provide therapeutic or preventive agents for various diseases or symptoms associated with a serotonin 4 receptor (particularly, neuropsychiatric diseases such as Alzheimer-type dementia). SOLUTION: The present invention provides a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. In the formula (1), Het represents formula (Het-1) or the like, A represents formula (A-1) or the like, B represents (B-1) or the like, R1A represents a hydrogen atom, an alkyl group or the like, R2A, R5, R6 and R7 represent a hydrogen atom, a halogen atom, an alkyl group or the like, R8 and R9 represent a hydrogen atom, an alkyl group or the like, and l represents an integer of 0-4. SELECTED DRAWING: None COPYRIGHT: (C)2016,JPOandINPIT
